The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for October 15, 2021
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA


Earnings News

Other News
Boehringer Ingelheim (expansion)
Boehringer Ingelheim (Nexgard Combo)
Bond Vet
Chanelle Pharma
JD Pet
Laboratorios Hipra
Warburg Pincus


  • Vetoquinol reported financial results for the third quarter of 2021. Revenues were EUR 132 million ($153 million), up 14% at constant exchange rates compared with the same period of the previous year. (Businesswire)


  • Bond Vet announced a $170 million investment from Warburg Pincus, a leading global growth investor. The funding will be used to expand Bond Vet’s footprint and invest in equipment, training, culture and technology. Bond Vet offers veterinary care in the New York City area with clinics providing a wide range of appointment options including pre-scheduled appointments, walk-in visits, and telehealth. (
  • EU Zoetis announced that the Committee for Medicinal Products for Veterinary Use of the European Medicines Agency adopted a positive opinion for Apoquel (noclacitinib maleate) chewable tablets. The product is currently available as a film-coated tablet. (IHS Markit Connect)
  • EU Boehringer Ingelheim Animal Health announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency recently recommended a grouped type II variation application for NexGard Combo in cats for new indications for the treatment of Notoedres cati mites, the treatment of infections with Aelurostrongylus abstrusus, prevention of aelurostrongylosis, and to support the safe use of the product in breeding, pregnant and lactating queens. (IHS Markit Connect)
  • FRANCE Boehringer Ingelheim announced an additional EUR 100 million investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases (highly contagious and transmissible epidemic diseases of animals). The investment follows an initial 200 million EUR investment in a new veterinary public health strategic production center in Lyon.  (company press release)
  • EU Chanelle Pharma announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) adopted a positive opinion of Imoxat (generic imidacloprid and moxidectin) spot-on solutions for cats, dogs and ferrets. (IHS Markit Connect)
  • EU Laboratorios Hipra announced it has received a marketing authorization recommendation for Suiseng Diff/A for the passive immunization of neonatal piglets via active immunization of breeding sows and gilts to prevent mortality and reduce clinical signs and macroscopic lesions caused by Clostridioides difficile, toxins A and B. It is also designed to reduce clinical signs and macroscopic lesions caused by Clostridium perfringens type A, α-toxin. (IHS Markit Connect)
  • GERMANY Verovaccines announced it has raised series B funding in the range of “mid-seven-figures” for its yeast-based vaccine platform that allows production of virus antigens without using cell culture and live virus materials. Verovaccines is working on a pipeline of vaccines against unspecified pathogens in pigs, cattle and poultry. (IHS Markit Connect)
  • EU Vetcare announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Veterinary Use has recommended Zenalpha – an injectable analgesic containing medetomidine hydrochloride/vatinoxan hydrochloride – for marketing approval. Zenalpha is indicated to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes. (IHS Markit Connect)
  • CANADA ezyVet announced that Ontario Veterinary College has partnered with ezyVet as their veterinary practice management software. (company press release)
  • CHINA JD Health and JD Pet – divisions of Chinese tech giant – announced the launch of a healthcare service platform called JD Pet Hospital, which will provide Chinese pet owners with 24/7 online pet health consultation services through text, images and video calls.  JD Pet already offers a series of prime pet services including a quality certification program for pet food, a “taste first and free return” service, pet insurance and more. (



  • BRAZIL – CSF Brazil has notified the World Organization for Animal Health (OIE) of a case of classical swine fever in the country, which had not occurred since November 2019. The disease was diagnosed in an animal from a backyard production in Ceará. The Brazilian government stressed that Ceará is not part of the CSF-free zone in Brazil and that there are restrictions on the movement of animals and products between the state and the rest of the country. (
  • GERMANY – BSE Germany has reported a case of atypical bovine spongiform encephalopathy (BSE) in a 14-year-old cow in south of the country. (
  • US – CANNABIS Beginning this month, veterinarians licensed in Nevada can recommend and administer hemp and cannabidiol products containing not more than 0.3% THC without fear of sanction from the state licensing board.  Nevada became the first state to legalize the use of cannabinoids as a veterinary treatment earlier this year; Nevada previously approved medical marijuana for people in 2000 and its recreational use in 2017. (JAVMA)
  • US – TOXICOLOGY SERVICE A new call-in service will help livestock veterinarians diagnose toxicology problems in their cattle, small ruminant and swine patients. The hotline is part of a “veterinary toxicology training program” created by Kansas State University using a $248,000 USDA grant. In addition to the hotline, the project will use other telemedicine and distance-based education resources, as well as YouTube training videos, to assist veterinarians. (Vet Advantage)


One Health – the collaborative, multisectoral, and transdisciplinary approach that recognizes that the health of people is closely connected to the health of animals and our shared environment – is pretty familiar to most of us in the animal health profession.  While it is substantially less recognized from the human health perspective, the cross-species transmissibility of SARS-CoV-2 has shone a light on the importance of understanding how diseases can impact both human and animal health.

A couple of weeks ago we reported on new research from the University of Glasgow that uses machine learning to make “actionable predictions” as to which animal viruses could go on to infect humans in the future, using only viral genome data.  According to the researchers, they were able to accurately predict that SARS-CoV-2 had a high likelihood of going on to infect humans.  While the platform isn’t able to predict how serious the symptoms of a disease will be, identifying those viruses that can make the leap is the first step in getting ahead of a pandemic scenario like the one the world has been living the past 18 months.  In the words of Sun Tzu, “If you know the enemy and know yourself, you need not fear the result of a hundred battles.”

Lynn Fondon


Last week we asked whether job turnover was impacting you.  Not surprisingly, at the organization level 57% of you said that employee turnover is higher, and nearly everyone else said it was about the same. From a personal perspective 81% of you said you hadn’t changed jobs in the past year, while 13% had changed employers.

This week

I was interested to read in this week’s news that Nevada has become the first state to give its blessing to the veterinary use of cannabidiols (CBD).  Although not approved for veterinary use by the FDA, CBD supplements for pets are widely available, and are sold both through veterinarians and directly to pet owners. Let’s find out where you stand on this hot-button topic.

Would you consider giving your pet a CBD supplement, if your veterinarian suggested it could help your pet?

en_USEnglish (United States)